Zydus Lifesciences Ltd Financial Statement - Zydus Lifesciences Ltd Balance Sheet | Research 360 by Motilal Oswal
11:49 Mar 02

Zydus Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
921.75
-3.60 (-0.39%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Zydus Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
921.75
-3.60 (-0.39%)
11:49 Mar 02
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

70/100
Technically Moderately Bullish

Strength

8

Weakness

2

Opportunity

2

Threats

1

11.19 %

ROE %

7.61 %

ROA %

19.30

EPS

194.55

BVPS

11.37 %

Net Profit Margin

Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM 2023
Net Sales
14253.1 14403.5 15265.2 17237.4 19024.2
Operating Expenses +
11469.7 11016.4 11924.5 13377.5 14014.8
Raw Material
5013.8 4958.3 5907.5 6072 6418.4
Increase Decrease in Cost
-93.8 -156.2 -362.3 238.1 -105.7
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2395.8 2295.1 2434.1 2765.6 3024.5
Miscellaneous Expenses
7262.3 6497.8 7674.4 8200.6 4677.6
Operating Profit
2783.4 3387.1 3340.7 3859.9 5009.4
Other Income
113.9 45.6 224.7 186.6 165.5
Depreciation
696.5 669.6 713 722.7 737.4
Interest
341.8 158.8 127 129.9 74.3
Profit before tax and exceptio..
1859 2604.3 2725.4 3193.9 4363.2
Exceptional Items
-363.6 -205.1 112.7 -604.2 -615.5
PBT
1495.4 2399.2 2838.1 2589.7 4978.7
Provision for Taxation
319.8 193.6 511.7 587.8 793.5
Net Profit
1175.6 2137.6 4572.1 1997.3 2971.8
NET Profit after MI
1176.6 2133.6 4487.3 1960.3 2973.8
EPS
11.49 20.84 43.83 19.3 29.38
Operating Profit Margin (%)
19.53 23.52 21.88 22.39 26.33
Net Profit Margin (%)
8.26 14.81 29.4 11.37 15.63

ShareHolding

All Data in Percentage (%)

Dec 23 Sep 23 Jun 23 Mar 23 Dec 22
Promoter 75.00 75.00 75.00 75.00 75.00
FII 5.00 4.80 4.00 3.40 2.50
MF 7.00 5.90 5.80 5.60 5.60
Public 7.00 7.10 7.50 8.00 8.80
Others 6.00 7.20 7.70 8.00 8.10
Shareholder Shares Holding %

Download Our App On: